Yang Xiangying, Lin Yao, Tang Amao, Zeng Xiaokang, Dai Weiying, Zhang Qian, Ning Li
Department of Intensive Care Unit, Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University, Hangzhou, China.
Department of Gastroenterology, Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University, Hangzhou, China.
BMC Med Inform Decis Mak. 2025 Feb 7;25(1):65. doi: 10.1186/s12911-025-02876-1.
ECMO treatment for critically ill patients mostly requires family members to make surrogate decisions. However, the process and experience of family members' participation in decision making have not been well described.
To explore the experience of family members of critically ill patients who were asked to consent to ECMO treatment and to gain insight into the factors that promote and hinder their decision-making.
A descriptive qualitative study. Data were collected using a semi-structured interview method and analysed using traditional content analysis approaches. The cohort included nineteen family members of critically ill ICU patients from a general hospital in China.
Eleven family members consented to ECMO treatment, and 8 refused. 4 themes and 10 subthemes emerged: (1) tough choices: the dilemma in the emergency situation, the guilt and remorse after giving up; (2) rationalisation of decision-making: ethics and morality guide decision-making, expected efficacy influences decision making, and past experience promotes decision making; (3) decision-making methods: independent decision-making, group decision-making, decision making based on patient preferences; (4) influencing factors of decision making: information and communication, social support.
The findings provide insights and a basis for promoting efficient ECMO decision-making in clinical practice. It may be difficult to improve the time it takes to make the decision without sacrificing the quality of the decision. Healthcare professionals should provide timely emotional support, informational support, and comprehensive social support to assist them in making efficient decisions while respecting the treatment preferences of the decision-makers.
危重症患者的体外膜肺氧合(ECMO)治疗大多需要家庭成员做出替代决策。然而,家庭成员参与决策的过程和体验尚未得到充分描述。
探讨被要求同意ECMO治疗的危重症患者家庭成员的体验,并深入了解促进和阻碍其决策的因素。
一项描述性定性研究。采用半结构化访谈方法收集数据,并使用传统内容分析方法进行分析。该队列包括来自中国一家综合医院重症监护病房(ICU)的19名危重症患者的家庭成员。
11名家庭成员同意ECMO治疗,8名拒绝。出现了4个主题和10个子主题:(1)艰难抉择:紧急情况下的困境,放弃后的内疚和悔恨;(2)决策合理化:伦理道德指导决策,预期疗效影响决策,既往经验促进决策;(3)决策方法:独立决策、集体决策、基于患者偏好的决策;(4)决策的影响因素:信息与沟通、社会支持。
这些发现为临床实践中促进高效的ECMO决策提供了见解和依据。在不牺牲决策质量的情况下,可能难以缩短决策所需的时间。医疗保健专业人员应提供及时的情感支持、信息支持和全面的社会支持,以帮助他们做出高效决策,同时尊重决策者的治疗偏好。